QIAGEN Operating Income 2006-2021 | QGEN

QIAGEN annual/quarterly operating income history and growth rate from 2006 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • QIAGEN operating income for the quarter ending September 30, 2021 was $0.132B, a 196.29% increase year-over-year.
  • QIAGEN operating income for the twelve months ending September 30, 2021 was $0.613B, a 97.37% increase year-over-year.
  • QIAGEN annual operating income for 2020 was $0.386B, a 1578.54% decline from 2019.
  • QIAGEN annual operating income for 2019 was $-0.026B, a 109.8% decline from 2018.
  • QIAGEN annual operating income for 2018 was $0.267B, a 73.76% increase from 2017.
QIAGEN Annual Operating Income
(Millions of US $)
2020 $386
2019 $-26
2018 $267
2017 $153
2016 $99
2015 $179
2014 $162
2013 $63
2012 $170
2011 $100
2010 $189
2009 $180
2008 $146
2007 $132
2006 $119
2005 $98
QIAGEN Quarterly Operating Income
(Millions of US $)
2021-09-30 $132
2021-06-30 $161
2021-03-31 $164
2020-12-31 $156
2020-09-30 $45
2020-06-30 $119
2020-03-31 $67
2019-12-31 $80
2019-09-30 $-207
2019-06-30 $60
2019-03-31 $41
2018-12-31 $88
2018-09-30 $77
2018-06-30 $53
2018-03-31 $48
2017-12-31 $43
2017-09-30 $64
2017-06-30 $22
2017-03-31 $24
2016-12-31 $4
2016-09-30 $48
2016-06-30 $30
2016-03-31 $17
2015-12-31 $58
2015-09-30 $46
2015-06-30 $40
2015-03-31 $35
2014-12-31 $21
2014-09-30 $50
2014-06-30 $48
2014-03-31 $42
2013-12-31 $34
2013-09-30 $34
2013-06-30 $-34
2013-03-31 $29
2012-12-31 $49
2012-09-30 $39
2012-06-30 $45
2012-03-31 $36
2011-12-31 $-20
2011-09-30 $34
2011-06-30 $46
2011-03-31 $38
2010-12-31 $51
2010-09-30 $50
2010-06-30 $43
2010-03-31 $45
2009-12-31 $35
2009-09-30 $53
2009-06-30 $51
2009-03-31 $41
2008-12-31 $3
2008-09-30 $52
2008-06-30 $46
2008-03-31 $46
2007-12-31 $41
2007-09-30 $29
2007-06-30 $32
2007-03-31 $30
2006-12-31 $126
2006-09-30 $28
2006-06-30 $113
2006-03-31 $109
2005-12-31 $26
2005-09-30 $26
2005-06-30 $24
2005-03-31 $21
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $11.301B $1.870B
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $143.345B 9.06
Bio-Rad Laboratories (BIO.B) United States $18.101B 36.73
Biohaven Pharmaceutical Holding (BHVN) United States $7.598B 0.00
Emergent Biosolutions (EBS) United States $2.503B 9.00
Arcus Biosciences (RCUS) United States $2.274B 0.00
Myovant Sciences (MYOV) United Kingdom $1.296B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.081B 0.00
Zymeworks (ZYME) Canada $0.538B 0.00
SQZ Biotechnologies (SQZ) United States $0.203B 0.00
Ambrx Biopharma (AMAM) United States $0.201B 0.00
Enzo Biochem (ENZ) United States $0.155B 20.00